Clinical Trials

Other hematologic neoplasm

40 enrolled

Leukemia, Biphenotypic, Acute

NCT07488572 2026-03-23

Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

60 enrolled

Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT06650748 2026-03-17

NeoMARS

100 enrolled

Breast Neoplasms

NCT07441369 2026-03-02

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

16 enrolled

Liver Metastases From Colorectal Cancer (mCRC)

NCT06250777 2026-02-09

ELPIS

27 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06648785 2026-02-05

Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies

20 enrolled

GI Cancers

NCT07386704 2026-02-04

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

30 enrolled

Pancreatic Cancer Non-resectable

NCT07363031 2026-01-23

Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy

84 enrolled

Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT07359404 2026-01-22

Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC

60 enrolled

Advanced Breast Cancer

NCT07344220 2026-01-15

DZ-002-201

39 enrolled

Pancreatic Neoplasms

NCT07139951 2025-12-31

HORIZON

16 enrolled

Clinical Stage I Gastric Cancer AJCC v8

NCT07312578 2025-12-31

Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma

48 enrolled

Esophageal Squamous Cell Carcinoma

NCT07310069 2025-12-30

TRANSFORM-GBC

44 enrolled

Gallbladder Neoplasms

NCT07275463 2025-12-22

[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression

40 enrolled

Breast Neoplasms

NCT07292571 2025-12-18

Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107

Breast Neoplasms

NCT06843681 2025-11-28

Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study

54 enrolled

Breast Carcinoma In Situ

NCT06723015 2025-11-18

Tau PET Outcomes With Anti-amyloid Immunotherapies

135 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT06680596 2025-09-22

SAFIR3LibHERty

80 enrolled

Breast Neoplasms

NCT07167459 2025-09-11

Personalized SBRT in Early-Stage Peripheral NSCLC

251 enrolled

Early-stage Peripheral Non-small Cell Lung Cancer

NCT07130149 2025-08-19

Sonodynamic-Chemoradiotherapy Integration in Glioblastoma

230 enrolled

CNS

Glioblastoma

NCT07101900 2025-08-08

68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

100 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT06688175 2025-08-07

IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma

32 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT06054178 2025-07-28

Identification of Nerves Using Fluorescein Sodium

30 enrolled

Head & NeckLymphoid

Adenolymphoma, Thyroid Diseases

NCT06999148 2025-05-31

Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis

216 enrolled

CNS

Glioma

NCT06419179 2025-05-20

GUIDANCE

29 enrolled

Small Cell Lung Carcinoma

NCT06963060 2025-05-08

GALENT-BT

44 enrolled

Gallbladder Neoplasms, Cholangiocarcinoma

NCT02646839 2025-05-04

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04836390 2025-05-04

EXCEL

Other hematologic neoplasm

30 enrolled

Leukemia, Myeloid, Acute

NCT06931613 2025-04-17

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

20 enrolled

Lymphoid

Hodgkin Disease, Recurrence

NCT06901622 2025-03-30

Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma

Gallbladder Neoplasms, Cholangiocarcinoma

NCT06786780 2025-03-26

ECCO

Gynecologic

Uterine Cervical Neoplasms

NCT06816966 2025-02-10

CISART

35 enrolled

Small Cell Lung Carcinoma

NCT06773156 2025-01-14

Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer

37 enrolled

Small Cell Lung Carcinoma

NCT06664970 2024-10-30

A Multicenter Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor

39 enrolled

MDS

NCT05170919 2024-09-19

Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer

170 enrolled

Anorexia Nervosa with Significantly Low Body Weight

NCT06481956 2024-07-01

T-DM1 Combined With CDK4/6 Inhibitor Ribociclib

40 enrolled

HER2-positive Advanced Breast Cancer

NCT05396118 2024-05-14

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

BreastEndocrineLymphoidNETSarcoma

15 enrolled

Breast Neoplasms, Lymphoma, Sarcoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT05576389 2022-11-15

Neoadjuvant Fluzoparib Combined With Camrelizumab in Germline BRCA-mutated HER2-negative Breast Cancer

94 enrolled

Germline BRCA-mutated HER2-negative Breast Cancer

NCT05171335 2022-09-21

Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04361370 2021-04-19

OPEB-01

44 enrolled

Gynecologic

Ovarian Neoplasms

NCT03815279 2019-08-16

iStopMM